Rituximab in the treatment of nodal Bcell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis
Rituximab in the treatment of nodal B- cell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis A case of nodal B- cell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis treated with rituximab is presented.
Saved in:
| Main Authors: | O A Logvinenko, VI Vasiljev, A M Kovrigina, N. V. Kokosadse, I. V. Gaiduk, B. V. Mitrikov, M. V. Maevskaya, E L Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2008-10-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/555 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USE OF RITUXIMAB IN PATIENTS WITH SYSTEMIC MANIFESTATIONS OF PRIMARY SJOGREN'S SYNDROME
by: O. A. Logvinenko, et al.
Published: (2014-12-01) -
Evaluation of effectiveness of long-term therapy with Russian rituximab biosimilar in Sjogren’s disease in real clinical practice
by: B. D. Chaltsev, et al.
Published: (2025-07-01) -
Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren’s syndrome
by: Xiao Zheng, et al.
Published: (2025-06-01) -
Efficacy of early rituximab treatment in primary Sjögren’s syndrome: a systematic review and meta-analysis
by: Mohammad Shahdadian, et al.
Published: (2025-07-01) -
Secondary Thrombocytopenia with Primary Sjogren's Syndrome: A Rare Presentation
by: Sanchu T. K. Sreeraj, et al.
Published: (2021-07-01)